Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to Evidence

SIMPLE SUMMARY: Hodgkin lymphoma (HL) is a highly curable disease; in this context, the limitation of late adverse events is of prime importance for the patient. Proton therapy for mediastinal HL irradiation theoretically limits secondary cancer excess risk and should reduce late toxicities compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Loap, Pierre, Mirandola, Alfredo, De Marzi, Ludovic, Dendale, Remi, Iannalfi, Alberto, Vitolo, Viviana, Barcellini, Amelia, Filippi, Andrea Riccardo, Jereczek-Fossa, Barbara Alicja, Kirova, Youlia, Orlandi, Ester
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345146/
https://www.ncbi.nlm.nih.gov/pubmed/34359647
http://dx.doi.org/10.3390/cancers13153746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345146/
https://www.ncbi.nlm.nih.gov/pubmed/34359647
http://dx.doi.org/10.3390/cancers13153746

Ejemplares similares